Last reviewed · How we verify
Vivax malaria
Approved treatments
- Artesunate · Amivas
- Hydroxychloroquine Sulfate · Sanofi
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and modulating the immune system to treat autoimmune diseases. - Halfan · GSK
- Arsuamoon · Pfizer
- Lariam
- Aralen · Sanofi
Aralen works by accumulating in the acidic compartments of the malaria parasite, disrupting its metabolism and ultimately leading to its death. - Hydroxychloroquine Sulfate · Advanz
Hydroxychloroquine Sulfate works by interfering with the replication of malaria parasites and reducing inflammation in the body. - Lariam
- Hydroxychloroquin · Children's Hospital of Fudan University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Vivax malaria patent landscape — cliff calendar, originator estates, attackable patents
- Vivax malaria treatment landscape brief
- Vivax malaria treatment updates RSS
Frequently asked questions about Vivax malaria
What drugs treat Vivax malaria?
Tracked treatments include Artesunate, Hydroxychloroquine Sulfate, Halfan, Arsuamoon, Lariam, Aralen, Hydroxychloroquin.
What is the treatment for Vivax malaria?
Standard treatment for Vivax malaria includes Artesunate, Hydroxychloroquine Sulfate, Halfan, Arsuamoon, Lariam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Vivax malaria patent cliff · Vivax malaria CI report
- Treatment: Artesunate · Amivas
- Treatment: Hydroxychloroquine Sulfate · Sanofi
- Treatment: Halfan · GSK
- Treatment: Arsuamoon · Pfizer
- Treatment: Lariam
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing